{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T17:13:34Z","timestamp":1789146814586,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,11]],"date-time":"2027-09-11T00:00:00Z","timestamp":1820620800000},"content-version":"am","delay-in-days":375,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1S10OD021644-011A1"],"award-info":[{"award-number":["1S10OD021644-011A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.urology.2026.06.016","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T17:58:43Z","timestamp":1781459923000},"page":"162-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Treatment-related Risk of Urologic Adverse Events in Cervical Cancer Survivors"],"prefix":"10.1016","volume":"215","author":[{"given":"Jordan","family":"Powell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy B.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J.","family":"Horns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarah","family":"Woodle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Dood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane T.","family":"Kurtzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2026.06.016_bib1","unstructured":"US Cancer Statistics Working Group. US Department of Health and Human Services C for DC and P and NCI. United States Cancer Statistics: 1999-2009 Incidence and Mortality Web-Based Report; 2013."},{"key":"10.1016\/j.urology.2026.06.016_bib2","first-page":"363","article-title":"Cancer treatment and survivorship statistics, 2019","volume":"69","author":"Miller","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urology.2026.06.016_bib3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/cncr.20444","article-title":"Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part I - malignancies of the cervix, ovary, vagina, and vulva","volume":"101","author":"Delaney","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2026.06.016_bib4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1002\/cncr.20445","article-title":"Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part II - carcinoma of the endometrium","volume":"101","author":"Delaney","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2026.06.016_bib5","unstructured":"Nationally Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Cervical Cancer."},{"key":"10.1016\/j.urology.2026.06.016_bib6","first-page":"186","article-title":"Urinary adverse effects of pelvic radiotherapy","volume":"3","author":"Liberman","year":"2014","journal-title":"Transl Androl Urol"},{"key":"10.1016\/j.urology.2026.06.016_bib7","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000072091","article-title":"Manifestation, latency and management of late urological complications after curative radiotherapy for cervical carcinoma","volume":"26","author":"Gellrich","year":"2003","journal-title":"Oncol Res Treat"},{"key":"10.1016\/j.urology.2026.06.016_bib8","unstructured":"National Cancer Institute DSRP. Surveillance and End Results (SEER) Program Populations (1995-2021)."},{"key":"10.1016\/j.urology.2026.06.016_bib9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ijrobp.2015.02.025","article-title":"Propensity-weighted comparison of long-term risk of urinary adverse events in elderly women treated for cervical cancer","volume":"92","author":"Elliott","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.urology.2026.06.016_bib10","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/AOG.0000000000001436","article-title":"Utilization and toxicity of alternative delivery methods of adjuvant chemotherapy for ovarian cancer","volume":"127","author":"Wright","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.urology.2026.06.016_bib11","article-title":"Adjuvant and first line chemotherapy use for endometrial cancer","volume":"41","author":"Knisely","year":"2022","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.urology.2026.06.016_bib12","unstructured":"Services M. CMS Manual System Department of Health & Human Services (DHHS) Pub. 100-04 Medicare Claims Processing Centers for Medicare & X Business Requirements X Manual Instruction Confidential Requirements One-Time Notification Recurring Update Notification *Medicare Contractors Only; 2004. \u3008www.cms.hhs.gov\/medlearn\/matters\u3009."},{"key":"10.1016\/j.urology.2026.06.016_bib13","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/pds.5204","article-title":"Validation of an International Classification of Disease, 10th revision coding adaptation for the Charlson Comorbidity Index in United States healthcare claims data","volume":"30","author":"Beyrer","year":"2021","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.urology.2026.06.016_bib14","unstructured":"Team RC. R: a language and environment for statistical computing. R Foundation for Statistical Computing. Preprint posted online 2024."},{"key":"10.1016\/j.urology.2026.06.016_bib15","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/cncr.20235","article-title":"Long-term bladder function in patients with locally advanced cervical carcinoma treated with neoadjuvant chemotherapy and type 3\u20134 radical hysterectomy","volume":"100","author":"Benedetti-Panici","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2026.06.016_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/gyno.2000.6030","article-title":"High incidence of severe urologic complications following radiotherapy for cervical cancer in Japanese women","volume":"80","author":"Fujikawa","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.urology.2026.06.016_bib17","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0022-5347(01)64325-8","article-title":"Late urological complications and malignancies after curative radiotherapy for gynecological carcinomas","volume":"158","author":"Maier","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2026.06.016_bib18","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/1097-0142(19950201)75:3<836::AID-CNCR2820750315>3.0.CO;2-A","article-title":"Ureteral stricture as a late complication of radiotherapy for stage IB carcinoma of the uterine cervix","volume":"75","author":"McLntyre","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2026.06.016_bib19","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1158\/1055-9965.EPI-22-0793","article-title":"Cervical cancer stage at diagnosis and survival among women \u226565 years in California","volume":"32","author":"Cooley","year":"2023","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.urology.2026.06.016_bib20","unstructured":"NHS Cervical Screening Programme Audit of Invasive Cervical Cancer: National Report 1; 2023. https:\/\/www.gov.uk\/government\/publications\/cervical-screening-invasive-cervical-cancer-audit-."},{"key":"10.1016\/j.urology.2026.06.016_bib21","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.urology.2026.06.016_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.urpr.2015.10.006","article-title":"AUA White Paper on implementation of shared decision making into urological practice","volume":"3","author":"Makarov","year":"2016","journal-title":"Urol Pract"},{"key":"10.1016\/j.urology.2026.06.016_bib23","first-page":"239","article-title":"Decision aids for localized prostate cancer treatment choice: systematic review and meta-analysis","volume":"65","author":"Violette","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.urology.2026.06.016_bib24","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1001\/jama.2019.20675","article-title":"Patient-reported outcomes through 5 years for active surveillance, surgery, brachytherapy, or external beam radiation with or without androgen deprivation therapy for localized prostate cancer","volume":"323","author":"Hoffman","year":"2020","journal-title":"JAMA"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429526003705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429526003705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:51:21Z","timestamp":1789145481000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429526003705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":24,"alternative-id":["S0090429526003705"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2026.06.016","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment-related Risk of Urologic Adverse Events in Cervical Cancer Survivors","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2026.06.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}